Sera Prognostics Files 8-K: Regulation FD Disclosure
Ticker: SERA · Form: 8-K · Filed: Nov 24, 2025 · CIK: 1534969
Sentiment: neutral
Topics: disclosure, filing
TL;DR
Sera Prognostics filed an 8-K for Reg FD disclosure & exhibits. No major news yet.
AI Summary
On November 24, 2025, Sera Prognostics, Inc. filed an 8-K report. The filing primarily serves as a notification of a Regulation FD Disclosure and includes financial statements and exhibits. No specific material events or financial figures were detailed in the provided excerpt.
Why It Matters
This filing indicates Sera Prognostics is adhering to disclosure regulations, which is standard practice for publicly traded companies. Investors should review the full filing for any material updates.
Risk Assessment
Risk Level: low — The filing is a routine disclosure and does not appear to contain any negative or significant new information that would immediately impact the company's risk profile.
Key Players & Entities
- Sera Prognostics, Inc. (company) — Registrant
- November 24, 2025 (date) — Date of earliest event reported
- 2749 East Parleys Way Suite 200 (address) — Principal Executive Offices
- Salt Lake City, Utah 84109 (location) — Principal Executive Offices
- (801) 990-0520 (phone_number) — Registrant's Telephone Number
FAQ
What is the primary purpose of this 8-K filing by Sera Prognostics, Inc.?
The primary purpose of this 8-K filing is to provide a Regulation FD Disclosure and to include financial statements and exhibits.
On what date was this 8-K report filed or intended to be filed?
The report was filed as of November 24, 2025.
What is the principal executive office address for Sera Prognostics, Inc.?
The principal executive office address is 2749 East Parleys Way, Suite 200, Salt Lake City, Utah 84109.
What is the telephone number for Sera Prognostics, Inc.?
The telephone number for Sera Prognostics, Inc. is (801) 990-0520.
Under which section of the Securities Exchange Act of 1934 is this report filed?
This report is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Stats: 543 words · 2 min read · ~2 pages · Grade level 11.9 · Accepted 2025-11-24 08:05:26
Key Financial Figures
- $0.0001 — hich registered Class A Common Stock, $0.0001 par value per share SERA The Nasdaq
Filing Documents
- sera-20251124.htm (8-K) — 47KB
- sera-ex99_1.htm (EX-99.1) — 16KB
- img88505028_0.jpg (GRAPHIC) — 715KB
- img88505028_1.jpg (GRAPHIC) — 56KB
- 0001193125-25-292074.txt ( ) — 1157KB
- sera-20251124.xsd (EX-101.SCH) — 26KB
- sera-20251124_htm.xml (XML) — 5KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. On November 24, 2025, Sera Prognostics, Inc. (the "Company") issued a press release announcing that the findings of the P rematurity R isk Assessment Combined With Clinical I nterventions for Improving Neonatal outco ME s ("PRIME") study were accepted for publication in a peer-reviewed journal. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and incorporated by reference herein. The information contained in Item 7.01, including Exhibit 99.1 furnished herewith, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities under that section, nor shall it be deemed incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended, or into any filing or other document pursuant to the Exchange Act, except to the extent required by applicable law or regulation.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 99.1 Press release dated November 24, 2025. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SERA PROGNOSTICS, INC. Date: November 24, 2025 By: /s/ Austin Aerts Austin Aerts Chief Financial Officer